Project Grant HT94252510633
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $144K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $144,254.00 to Purdue University to conduct research on "ENDOTHELIAL-TO-MESENCHYMAL TRANSITION IN EPITHELIOID HEMANGIOENDOTHELIOMA." The award period runs from Aug 15, 2024 to Aug 14, 2026. As a prominent research university, Purdue University has extensive experience supporting U.S. government missions through federal contracts and...
- The Department of the Army Medical Command awarded Purdue University a $2,431,591 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through September 2026 to study the Role of Comorbid Military-Relevant Stressors in Osteoarthritis. Through this award, Purdue University researchers will investigate the impact of psychological and physiological stress experienced by military service members on the development...
- Purdue University will use a $465,000 Project Grant award from the Department of the Army Medical Command to support research titled "LIGAND-TARGETED MIRNA DELIVERY FOR PROSTATE CANCER THERAPY" from March 2021 to February 2023. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health care through innovative biomedical research solutions for battlefield medicine and other health issues....
- Purdue University will use a $1.14 million project grant from the Department of the Army Medical Command to target BRD9 in treatment-resistant prostate cancer. The grant was awarded on August 1, 2022 under the Military Medical Research and Development program (CFDA 12.420). For a three-year period ending July 31, 2025, Purdue researchers will investigate medical solutions for prostate cancer that does not respond to standard therapies by focusing on the role of the BRD9 gene. The Military...
- This $1,054,933 Department of Defense Project Grant awarded to Purdue University under the Military Medical Research and Development program (CFDA 12.420) will fund research to target NNMT (nicotinamide N-methyltransferase) in order to inhibit obesity-associated breast cancer development and progression. The 3-year award period runs from September 1, 2023 to August 31, 2026. As the prime awardee, Purdue University will conduct the biomedical research to investigate medical solutions for this...
- The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The University of Pittsburgh is the recipient of a $1,272,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant, titled "The Pittsburgh ASPIRES Bridge Builder Project: Connecting Advocates, Scientists, Patients, and Institutions for Research Expansion in Sarcoma," is intended to support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public....
- The U.S. Defense Health Agency awarded a $1,449,000 Project Grant to Duke University to conduct research aimed at "Identifying Essential Molecular Mechanisms for Advanced Prostate Cancer Growth by a New Chemical Compound." This grant is funded under the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to improve the health and care of military service members, veterans, and their families. The...
- This federal Project Grant award, issued under the Military Medical Research and Development program (CFDA 12.420) by the Department of the Army Medical Command, provides $1,502,238.00 to support the development of a universal, non-invasive system to detect autonomic dysreflexia in individuals with spinal cord injuries. The award was made to Purdue University, which will collaborate with Indiana University on this research initiative. The project aims to create an innovative diagnostic...